BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«S Phase

Below is an extended S Phase patents listing. Click here to return to the S Phase main in depth entry.

Patents :

US Patent No.Title
7399740 Poly-Glu,Tyr for neuroprotective therapy
7407946 Quinazoline compounds
7407971 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
7407985 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
7407988 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
7408041 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
7408095 Methods for introducing heterologous cells into fish to determine if the heterologous cells contain cancer cells or a pathogen
7409026 Device and method for detecting the phase of a signal
7410772 Compositions and methods for treatment of non-Hodgkin's lymphoma
7410774 Compounds modulating sister chromatid separation and method for identifying same
7410791 Device containing cytophilic islands that adhere cells separated by cytophobic regions
7407675 Anti-neoplastic compositions comprising extracts of black cohosh
7405314 Compounds and methods for the treatment of cancer
7405286 Stars--A muscle-specific actin-binding protein
7399850 Sequence-determined DNA fragments encoding AP2 domain proteins
7399884 Histone deacetylase inhibitors
7402228 Manufacturing method and apparatus of phase shift mask blank
7402557 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
7402585 Substituted quinazoline derivatives as inhibitors of aurora kinases
7405205 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
7405220 Pyrazolopyrimidines
7405227 Treatment of cancer
7405272 Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein
7405279 Chimeric proteins for diagnosis and treatment of diabetes
7411051 Antibodies to HDPPA04 polypeptide
7411995 Apparatus and related methods to aid in system identification in a heterogeneous communication system environment
7415359 Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
7415372 Method and apparatus for improving noise discrimination in multiple sensor pairs
7416723 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
7416818 Switchable volume hologram materials and devices
7416881 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
7417026 Mobilization of hematopoietic cells
7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
7417137 Non-squamous epithelium-specific transcription
7417179 Method of modifying epidermal outgrowth structures via modulating cell cycle control genes
7417409 Power losses reduction in switching power converters
7415358 Molecular toxicology modeling
7415144 Cell observation device and cell observation method
7414170 Transgenic bovines capable of human antibody production
7412333 Method for prognostic factor analysis regarding cancers
7413678 Electrically switchable polymer-dispersed liquid crystal materials
7413679 Tailoring material composition for optimization of application-specific switchable holograms
7413864 Treating cancer using a telomerase vaccine
7413899 Genes from the 20q13 amplicon and their uses
7413903 Methods of regulating differentiation in stem cells
7414020 Human checkpoint kinase, hCDS1, compositions and methods
7414035 hKIS composition and methods of use
7414077 Therapeutic intervention to mimic the effect of caloric restriction
7414105 Peptides that bind to the erythropoietin receptor
7418211 Control apparatus and control method for optical modulator
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional